<DOC>
	<DOCNO>NCT00114686</DOCNO>
	<brief_summary>The purpose study determine whether treatment Quetiapine Fumarate ( SEROQUEL ) conjunction mood stabilizer ( Lithium Divalproex ) 12 week help patient Bipolar I Disorder Alcohol Dependence</brief_summary>
	<brief_title>Efficacy Safety Quetiapine Fumarate ( SEROQUELÂ® ) Treatment Alcohol Dependency Patients With Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Meets criteria Bipolar I Disorder Alcohol dependence Outpatient Status Recent history heavy drinking Unstable medical illness Recent antipsychotic use Poorly control Diabetes Mellitus Diabetes relate illness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar I Disorder</keyword>
	<keyword>Alcohol Dependency</keyword>
</DOC>